These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Antifibrinolytic therapy in ruptured intracranial aneurysm through repeated monitoring of fibrinolytic activity of blood. Watanabe H; Ito M; Chigasaki H; Ishii S Neurol Med Chir (Tokyo); 1976; 16(PT1):91-6. PubMed ID: 66644 [No Abstract] [Full Text] [Related]
5. The use of antifibrinolytic drugs in aneurysmal subarachnoid hemorrhage. Schisano G Surg Neurol; 1978 Oct; 10(4):217-22. PubMed ID: 725719 [TBL] [Abstract][Full Text] [Related]
7. Spontaneous thrombosis of ruptured intracranial aneurysm during treatment with tranexanic acid. Case report. Tanghetti B; Capra R; Marini G J Neurosurg Sci; 1985; 29(2):105-8. PubMed ID: 4093796 [TBL] [Abstract][Full Text] [Related]
8. Preoperative management of patients with aneurysmal subarachnoid hemorrhage. Tovi D J Neurosurg Sci; 1975; 19(1-2):59-64. PubMed ID: 1221096 [No Abstract] [Full Text] [Related]
9. Prolonged antifibrinolysis: an effective non-surgical treatment for ruptured intracranial aneurysms? Maurice-Williams RS Br Med J; 1978 Apr; 1(6118):945-7. PubMed ID: 346153 [TBL] [Abstract][Full Text] [Related]
10. Antifibrinolytic therapy in subarachnoid hemorrhage caused by ruptured intracranial aneurysm. Ramirez-Lassepas M Neurology; 1981 Mar; 31(3):316-22. PubMed ID: 7010208 [TBL] [Abstract][Full Text] [Related]
11. Antifibrinolytic agents for ruptured intracranial aneurysms. Van Rossum J; Wintzen AR Br Med J; 1978 Aug; 2(6136):568. PubMed ID: 359088 [No Abstract] [Full Text] [Related]
12. Treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm with tranexamic acid: a double-blind clinical trial. Chandra B Ann Neurol; 1978 Jun; 3(6):502-4. PubMed ID: 354483 [TBL] [Abstract][Full Text] [Related]
13. Intracranial aneurysms and subarachnoid hemorrhage. A cooperative study. Antifibrinolytic therapy in recent onset subarachnoid hemorrhage. Nibbelink DW; Torner JC; Henderson WG Stroke; 1975; 6(6):622-9. PubMed ID: 1198627 [TBL] [Abstract][Full Text] [Related]
14. Current status of antifibrinolytic therapy for treatment of patients with aneurysmal subarachnoid hemorrhage. Adams HP Stroke; 1982; 13(2):256-9. PubMed ID: 7039006 [No Abstract] [Full Text] [Related]
15. Use of an anti-fibrinolytic agent (tranexamic acid) in the management of ruptured intracranial aneurysms. Gibbs JR; Corkill AG Postgrad Med J; 1971 Apr; 47(546):199-200. PubMed ID: 5576488 [No Abstract] [Full Text] [Related]
16. Antifibrinolytics in the treatment of subarachnoid hemorrhages due to ruptured aneurysms. Schisano G J Neurosurg Sci; 1975; 19(1-2):79-80. PubMed ID: 1082929 [No Abstract] [Full Text] [Related]
17. Effect of tranexamic acid on rebleeding after subarachnoid hemorrhage: a double-blind controlled clinical trial. van Rossum J; Wintzen AR; Endtz LJ; Schoen JH; de Jonge H Ann Neurol; 1977 Sep; 2(3):238-42. PubMed ID: 365072 [TBL] [Abstract][Full Text] [Related]
18. Emerging trend: new therapy for ruptured intracranial aneurysms. Check W JAMA; 1978 Nov; 240(20):2135-6, 2143. PubMed ID: 702711 [No Abstract] [Full Text] [Related]
19. The role of antifibrinolytic therapy in the preoperative management of recently ruptured intracranial aneurysms. Guidetti B; Spallone A Surg Neurol; 1981 Apr; 15(4):239-48. PubMed ID: 6166061 [TBL] [Abstract][Full Text] [Related]
20. Antifibrinolytic therapy in subarachnoid hemorrhage. Jordan KG N Engl J Med; 1985 Jan; 312(1):52-3. PubMed ID: 3880594 [No Abstract] [Full Text] [Related] [Next] [New Search]